Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Pediatric Blood & Cancer|May 12, 2018
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous systemPeter E Manley, Tanya Trippett, Amy A Smith, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Neuro-Oncology|August 15, 2014
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patientsElizabeth Vera-Bolanos, Kenneth Aldape, Ying Yuan, et al.
Pediatric Blood & Cancer|June 23, 2016
Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trialsJuan C Espinoza, Kelley Haley, Neha Patel, et al.
Neuro-Oncology Practice|March 18, 2024
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumorsMargaret Shatara, Megan Blue, Joseph Stanek, et al.
Pediatric Blood & Cancer|July 17, 2019
Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology GroupAdam J Esbenshade, Lisa S Kahalley, Reto Baertschiger, et al.
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.
The Lancet. Oncology|April 30, 2022
Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology GroupGiovanni Morana, Dennis Shaw, Shannon M MacDonald, et al.
Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.
Pageof 11